Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Save life and save cost with ivabradine.

Title : Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Save life and save cost with ivabradine.Speaker: Martin COWIE,London,GBRAbstract :  Clinical evidence suggests that an elevated resting heart rate is a risk factor for mortality and morbidity in heart failure (HF) patients. SHIfT examined the effect of adding ivabradine,a heart rate lowering therapy,to optimised standard therapy in HF patients with a heart rate ?70bpm,in sinus rhythm and with left ventricular systolic dysfunction.1 Ivabradine plus standard therapy significantly reduced the risk of a primary composite event (CV death and hospitalisation for worsening HF) versus standard therapy (hazard ratio 0.82,95% CI: 0.75-0.90 p

Disciplines : Sciences médicales. Médecine
Mots-clés : Cardiovascular Clinical Trialists,Paris,2012,Cardiovascular prevention,Baro-stimulation,ivabradine
Type de document : image en mouvement
Type de ressource : lecture
Niveau : higher education,formation continue
Auteurs ou éditeurs : Martin COWIE